Valuation: aap Implantate AG

Market Cap 22.67M 25.81M 21.08M 19.35M 36.35M 2.49B 36.91M 250M 97.82M 1.22B 96.91M 94.82M 4.23B P/E 2024
-3.6x
P/E 2025 -7.58x
Enterprise Value 22.36M 25.46M 20.79M 19.08M 35.85M 2.45B 36.4M 247M 96.46M 1.21B 95.56M 93.5M 4.17B EV / Sales 2024
1.31x
EV / Sales 2025 1.52x
Free-Float
38.21%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 64 2019-04-30
Director TitleAgeSince
Director/Board Member 70 2015-12-31
Chairman 54 2019-07-03
Director/Board Member 50 2021-10-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.67%-9.32% - - 25.81M
+2.29%+2.36%-17.97%-10.09% 180B
+1.46%+0.01%-9.87%-6.25% 107B
+1.58%+0.65%+6.69%+61.86% 60.29B
-1.13%-2.60%+26.37%+54.76% 50.19B
+2.22%-1.14%-14.85%-44.15% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-17.52%-43.99% 27.61B
-7.67%-8.39%+17.59%-12.73% 23.1B
+1.63%-1.73%-5.80%-7.80% 20.86B
Average +0.22%-2.24%-1.92%-1.05% 60.44B
Weighted average by Cap. +1.28%-0.40%-6.63%+0.84%

Financials

2024 2025
Net sales 12.29M 14M 11.43M 10.49M 19.71M 1.35B 20.01M 136M 53.04M 663M 52.54M 51.41M 2.29B 12.8M 14.58M 11.91M 10.93M 20.53M 1.4B 20.85M 141M 55.24M 690M 54.73M 53.55M 2.39B
Net income -3.63M -4.13M -3.38M -3.1M -5.82M -398M -5.91M -40.09M -15.66M -196M -15.52M -15.18M -677M -2.58M -2.94M -2.4M -2.21M -4.14M -283M -4.21M -28.55M -11.15M -139M -11.05M -10.81M -482M
Net Debt -1.1M -1.25M -1.02M -940K -1.77M -121M -1.79M -12.16M -4.75M -59.35M -4.71M -4.6M -205M -314K -358K -292K -268K -503K -34.43M -511K -3.47M -1.35M -16.93M -1.34M -1.31M -58.52M
Logo aap Implantate AG
aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
Employees
-